In our study, we found that in osimertinib-resistant NSCLC cells, the expression level of the EMT-related protein E-cadherin was lower than that in sensitive cells, while the expression level of ID1 and vimentin were higher than those in sensitive cells. This evidence concerns the gene VIM and non-small cell lung carcinoma.